We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 12, 2020

Denosumab for Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors

Journal of Bone and Mineral Metabolism

 

Additional Info

Journal of Bone and Mineral Metabolism
The Effect of Denosumab in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors: 36-Month Results
J. Bone Miner. Metab. 2020 Sep 05;[EPub Ahead of Print], Y Ouchi, K Nakatsukasa, K Sakaguchi, M Morita, H Koyama, T Matsuda, M Kato, E Konishi, H Ono, T Taguchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading